Skip to main content
Total Market Cap: $43,727,520,409 Volume (24h): $762,582,054

Cara Therapeutics Inc.

Cara Therapeutics Inc. (CARA) logo
Rank 15
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Website
$12.1000
USD
1.41%
Market cap
$561,654,170
Total volume
$3,898,269
Shares outstanding
46,417,700
Rank 15
Website
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
CARA
$3,898,269
100%
$12.1000
Chart
Social media

Share widget

Copy widget code
Subscribe to our newsletter